De Paermentier F, Mauger J M, Lowther S, Crompton M R, Katona C L, Horton R W
Department of Pharmacology and Clinical Pharmacology, St. George's Hospital Medical School, London, UK.
Brain Res. 1997 May 16;757(1):60-8. doi: 10.1016/s0006-8993(97)00138-8.
alpha1-Adrenoceptors and alpha2-adrenoceptors were measured by radioligand binding to homogenates of brain samples obtained at post-mortem from suicides with a retrospective diagnosis of depression, and age and gender-matched controls. Suicides were subdivided into those who had been free of antidepressant drugs for at least three months, and those in whom prescription of antidepressant drugs was clearly documented. The number of alpha1-adrenoceptors (or alpha1A + alpha1D-adrenoceptors) did not differ significantly between antidepressant-free or antidepressant-treated suicides and controls. In antidepressant-free suicides, the number of alpha2-adrenoceptors was significantly higher in temporal cortex (Ba 21/22). alpha2A-Adrenoceptors did not differ significantly from controls in this brain region, suggesting the involvement of other alpha2-adrenoceptor subtypes. In antidepressant-treated suicides, significantly lower numbers of alpha2-adrenoceptors were found in occipital cortex and hippocampus (and for alpha2A-adrenoceptors in caudate and amygdala) compared to controls.
通过放射性配体结合法,对死后从具有抑郁症回顾性诊断的自杀者以及年龄和性别匹配的对照者获取的脑样本匀浆进行检测,以测定α1肾上腺素能受体和α2肾上腺素能受体。自杀者被分为至少三个月未服用抗抑郁药物者,以及有明确抗抑郁药物处方记录者。未服用抗抑郁药物或服用抗抑郁药物的自杀者与对照者之间,α1肾上腺素能受体(或α1A + α1D肾上腺素能受体)的数量无显著差异。在未服用抗抑郁药物的自杀者中,颞叶皮质(BA 21/22)的α2肾上腺素能受体数量显著更高。该脑区的α2A肾上腺素能受体与对照者无显著差异,提示其他α2肾上腺素能受体亚型参与其中。与对照者相比,服用抗抑郁药物的自杀者在枕叶皮质和海马体中发现α2肾上腺素能受体数量显著更低(尾状核和杏仁核中的α2A肾上腺素能受体也是如此)。